Injectable Therapies & Premium Supplements
Pharmaceutical‑grade products for global healthcare
Browse ProductsEnoxaparin Injection 40 mg
A high-precision low molecular weight heparin (LMWH) manufactured in our GMP-compliant UK facility. Designed for the prevention and treatment of deep vein thrombosis and pulmonary embolism with clinical-grade reliability.
- Molecule: Enoxaparin Sodium (LMWH)
- Therapeutic Class: Anticoagulant / Antithrombotic
- GMP-compliant sterile manufacturing process
Retatrutide Injection
Our latest innovation in metabolic therapy. This triple hormone receptor agonist represents the pinnacle of our research and development, offering a sophisticated solution for advanced weight management and glycemic control.
- Molecule: Retatrutide (Triple Agonist)
- Therapeutic Class: Metabolic / Anti-Obesity
- Advanced R&D scientific innovation
Tirzepatide Injection
A dual GIP and GLP-1 receptor agonist engineered for maximum therapeutic efficacy. Produced under rigorous quality assurance protocols to ensure global pharmaceutical supply standards and patient safety.
- Molecule: Tirzepatide (Dual Agonist)
- Therapeutic Class: Antidiabetic / Weight Management
- Global pharmaceutical supply chain ready
Product Inquiry & Procurement
Connect with our pharmaceutical specialists for GMP-compliant manufacturing solutions and global supply chain inquiries.
Global Support
+44 (0) 20 7946 0000
Medical Inquiries
info@parkers-pharma.com
Headquarters
London, United Kingdom
Our Procurement Process
Technical Review
Our pharmaceutical experts review your product requirements and clinical specifications.
Compliance Assessment
We ensure all manufacturing protocols align with GMP and global regulatory standards.
Supply Chain Logistics
Coordination of secure, temperature-controlled distribution for injectable therapies.
Quality Assurance
Final batch testing and certification before global pharmaceutical dispatch.
Product Technical Specifications
Detailed clinical and regulatory information for our primary pharmaceutical portfolio.
Prevention of deep vein thrombosis (DVT) and pulmonary embolism.
40 mg once daily via subcutaneous injection.
Store at 25°C (77°F); excursions permitted to 15°C–30°C. Do not freeze.
GMP Certified, MHRA Approved.
Monitor for signs of bleeding or thrombocytopenia.
Investigational therapy for chronic weight management and glycemic control.
Titrated weekly dosage based on clinical protocol requirements.
Refrigerated storage (2°C to 8°C). Protect from light.
GMP Compliant Manufacturing for R&D and Clinical Trials.
Gastrointestinal monitoring required during titration phases.
Treatment of type 2 diabetes mellitus and chronic weight management.
Once-weekly subcutaneous injection with escalating dose schedule.
Store in refrigerator (2°C to 8°C). Stable at room temperature for up to 21 days.
GMP Certified Facility Production.
Contraindicated in patients with a personal or family history of MTC.